Related Experiment Video
Updated: Aug 14, 2026
In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
Published on: October 16, 2013
Anti-HIV effect of beta subunit of human chorionic gonadotropin (beta hCG) in vitro
1Department of Biochemistry, New York University Medical Center, NY 10016, USA.
Insights
Human chorionic gonadotropin (hCG) inhibits HIV replication. The beta subunit of hCG, not the alpha subunit, is responsible for this antiviral activity, suggesting a specific mechanism for its immune-modulating effects during pregnancy.
Area of Science:
- Immunology
- Virology
- Endocrinology
Background:
- Human chorionic gonadotropin (hCG) is a pregnancy hormone with known immunomodulatory effects.
- Previous in vitro studies indicated hCG's potential to suppress HIV activity and viral transmission.
Purpose of the Study:
- To investigate the mechanism of hCG's antiviral activity against HIV.
- To determine which subunit of hCG is responsible for inhibiting HIV replication.
Main Methods:
- Purified alpha and beta subunits of hCG were tested for their effect on p24 gag protein synthesis in HIV-infected cell lines (ACH-2 lymphocytes and U1 monocytes).
- Dose-response effects were analyzed, comparing concentrations to physiological levels in pregnant women.
Main Results:
- The beta subunit of hCG (beta-hCG) demonstrated significant inhibition of HIV replication, exhibiting a U-shaped dose-response curve similar to intact hCG.
- Maximum inhibition occurred at concentrations of 10-100 ng/ml, aligning with typical blood levels of beta-hCG during pregnancy.
- High doses of beta-hCG appeared to increase viral production in monocytes.
- The alpha subunit of hCG did not show significant antiviral activity.
Conclusions:
- The virus-interfering activity of hCG against HIV is mediated by its beta subunit, not the alpha subunit.
- These findings support the role of the beta-hCG subunit in the observed effects of intact hCG on HIV replication.
Abstract:
Human chorionic gonadotropin (hCG)--a pregnancy-associated immunomodulating hormone--has been recently shown in vitro to suppress reverse transcriptase activity in chronically HIV-infected lymphocytes and monocytes and to block viral transmission resulting from cell-cell contact between virus-carrying lymphocytes and placental trophoblasts. In further pursuit of the query into the mechanism of action, purified alpha and beta subunits of hCG were tested for the inhibition of p24 gag protein synthesis in virus-producing ACH-2 lymphocytes and U1 monocytes. Unlike the alpha subunit, beta-hCG displayed a distinct U-shaped dose response, characteristic of the effect of dimer hCG. Maximum inhibition of viral expression has been achieved at 10-100 ng/ml, the concentration corresponding to blood levels of beta-hCG in pregnant women. The doses that were several logs higher of normal levels seemed to increase viral production in monocytes. The data presented supports our original observations regarding the effect of intact hCG on HIV replication. While the mechanism of action remains to be established, the results suggest that the virus-interfering activity of hCG is determined by hormone-specific beta chain but not by the alpha subunit--shared with the family of glycoprotein hormones from the pituitary--follicle-stimulating hormone, luteinizing hormone and thyrotropin.
